AbbVie Inc. (ABBV) Financials Nov 20, 2014, 4:19 p
Post# of 250602
Posted On: 11/20/2014 7:37:41 PM
AbbVie Inc. (ABBV) Financials Nov 20, 2014, 4:19 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AbbVie Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 14.21B 15.64B 17.44B 18.38B 18.79B
Cost of Goods Sold (COGS) incl. D&A 4.05B 4.34B 4.62B 4.53B 4.55B
COGS excluding D&A 3.35B 3.15B 3.34B 3.38B 3.66B
Depreciation & Amortization Expense 697.49M 1.18B 1.27B 1.15B 897M
Depreciation 325.28M 476.02M 507.92M 525M 388M
Amortization of Intangibles 372.21M 708.34M 764.28M 625M 509M
Gross Income 10.17B 11.3B 12.83B 13.85B 14.24B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.03B 6.31B 8.39B 7.2B 7.95B
Research & Development 1.71B 2.49B 2.55B 2.6B 2.84B
Other SG&A 3.32B 3.82B 5.84B 4.6B 5.11B
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.02B 238.2M 840.5M 941M 637M
EBIT after Unusual Expense (1.02B) (238.2M) (840.5M) (941M) (637M)
Non Operating Income/Expense 1.83B 88.71M 73.8M 16M (43M)
Non-Operating Interest Income - - - 20M 21M
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 - 23M 299M
Gross Interest Expense 0 0 - 23M 299M
Interest Capitalized 0 0 0 0 0
Pretax Income 5.95B 4.84B 3.67B 5.73B 5.33B
Income Tax 1.31B 657.63M 235.4M 450M 1.2B
Income Tax - Current Domestic 499.8M 986.63M 177.4M 94M 226M
Income Tax - Current Foreign 257M 408M 390M 252M 354M
Income Tax - Deferred Domestic 608M (624M) (198M) 89M 678M
Income Tax - Deferred Foreign (51M) (113M) (134M) 15M (54M)
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.64B 4.18B 3.43B 5.28B 4.13B
Minority Interest Expense 0 0 0 0 0
Net Income 4.64B 4.18B 3.43B 5.28B 4.13B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.64B 4.18B 3.43B 5.28B 4.13B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.64B 4.18B 3.43B 5.28B 4.13B
EPS (Basic) 2.93 2.64 2.17 3.35 2.58
Basic Shares Outstanding 1.58B 1.58B 1.58B 1.58B 1.59B
EPS (Diluted) 2.93 2.64 2.17 3.35 2.56
Diluted Shares Outstanding 1.58B 1.58B 1.58B 1.58B 1.6B
EBITDA 5.83B 6.17B 5.71B 7.8B 7.19B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AbbVie Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 14.21B 15.64B 17.44B 18.38B 18.79B
Cost of Goods Sold (COGS) incl. D&A 4.05B 4.34B 4.62B 4.53B 4.55B
COGS excluding D&A 3.35B 3.15B 3.34B 3.38B 3.66B
Depreciation & Amortization Expense 697.49M 1.18B 1.27B 1.15B 897M
Depreciation 325.28M 476.02M 507.92M 525M 388M
Amortization of Intangibles 372.21M 708.34M 764.28M 625M 509M
Gross Income 10.17B 11.3B 12.83B 13.85B 14.24B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 5.03B 6.31B 8.39B 7.2B 7.95B
Research & Development 1.71B 2.49B 2.55B 2.6B 2.84B
Other SG&A 3.32B 3.82B 5.84B 4.6B 5.11B
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.02B 238.2M 840.5M 941M 637M
EBIT after Unusual Expense (1.02B) (238.2M) (840.5M) (941M) (637M)
Non Operating Income/Expense 1.83B 88.71M 73.8M 16M (43M)
Non-Operating Interest Income - - - 20M 21M
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 0 0 - 23M 299M
Gross Interest Expense 0 0 - 23M 299M
Interest Capitalized 0 0 0 0 0
Pretax Income 5.95B 4.84B 3.67B 5.73B 5.33B
Income Tax 1.31B 657.63M 235.4M 450M 1.2B
Income Tax - Current Domestic 499.8M 986.63M 177.4M 94M 226M
Income Tax - Current Foreign 257M 408M 390M 252M 354M
Income Tax - Deferred Domestic 608M (624M) (198M) 89M 678M
Income Tax - Deferred Foreign (51M) (113M) (134M) 15M (54M)
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.64B 4.18B 3.43B 5.28B 4.13B
Minority Interest Expense 0 0 0 0 0
Net Income 4.64B 4.18B 3.43B 5.28B 4.13B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.64B 4.18B 3.43B 5.28B 4.13B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.64B 4.18B 3.43B 5.28B 4.13B
EPS (Basic) 2.93 2.64 2.17 3.35 2.58
Basic Shares Outstanding 1.58B 1.58B 1.58B 1.58B 1.59B
EPS (Diluted) 2.93 2.64 2.17 3.35 2.56
Diluted Shares Outstanding 1.58B 1.58B 1.58B 1.58B 1.6B
EBITDA 5.83B 6.17B 5.71B 7.8B 7.19B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)Scroll down for more posts ▼